AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday reported a modest profit for the fourth quarter of 2022 compared to breakeven last year. Revenues
ANGO Earnings: AngioDynamics swings to profit in Q4; revenues beat estimates
Categories
Medical Devices
Abbott Laboratories (ABT) stock remains a compelling buy. Here’s why
Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its diagnostics segment
ANGO Stock: Is it the right time to invest in AngioDynamics now?
The performance of AngioDynamics, Inc. (NASDAQ: ANGO) has not been very impressive lately, despite being part of a rapidly growing industry. But
Stock Watch: Intuitive Surgical (ISRG) remains a good bet despite slowdown
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a market leader in the manufacturing and distribution of robotics-assisted surgical systems. The company’s products, designed for
OptMed all set for $24 million IPO. Here’s what you need to know
As IPO activity picks up momentum after a lull, technology and healthcare companies are dominating the scene as usual. The upcoming initial
Stock Watch: Key factors to consider before investing in Medtronic (MDT)
More than two years into the pandemic, the healthcare sector remains under stress due to continuing COVID care activities and hospitalizations. However,
MDT Earnings: Highlights of Medtronic’s Q4 2022 results
Medical device maker Medtronic plc (NYSE: MDT) has reported an increase in profit for the fourth quarter of 2022, despite a modest
Medtronic PLC (MDT) Q4 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q4 2022 earnings call dated May. 26, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Boston Scientific Corp. (BSX) Q1 2022 Earnings Call Transcript
Boston Scientific Corp. (NYSE: BSX) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Infographic: Highlights of Intuitive Surgical’s Q1 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a decline in first-quarter earnings despite a double-digit growth in revenues, hurt
Abbott Laboratories (ABT) Q1 2022 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations Robert B. Ford -- Chairman
AngioDynamics (ANGO) Q3 earnings beat estimates as sales increase
AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported higher earnings for the third quarter of 2022 when the medical device maker's net sales
Why Intuitive Surgical (ISRG) is a must-own stock after the recent dip
The pandemic had a mixed impact on the healthcare sector. The high demand for COIVD care services sent medical facilities into overdrive,
Medtronic PLC (MDT) Q3 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q3 2022 earnings call dated Feb. 22, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head, Investor Relations Karen
Meihua’s IPO might set the stage for revival of Chinese listings in the US
Meihua International Medical Technologies is the latest healthcare company to seek Wall Street listing, even as the IPO market picks up momentum
Boston Scientific Corp (BSX) Q4 2021 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
Edwards Lifesciences Corporation (EW) Q4 2021 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE: EW) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Mark Wilterding -- Vice President, Investor Relations & Treasurer
Abbott Laboratories (ABT) Q4 2021 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing & Acquisitions
Royal Philips NV (PHG) Q4 2021 Earnings Call Transcript
Royal Philips NV (AMS: PHG) Q4 2021 earnings call dated Jan. 24, 2022 Corporate Participants: Leandro Mazzoni -- Head of Investor Relations Frans van
IPO Alert: Here’s all you need to know about Bausch + Lomb’s market debut
After slowing down in the final weeks of 2021, IPO activity has picked up momentum despite the uncertain economic conditions. Eye care
Here are 2 top stock picks to enrich your portfolio in the new year
For businesses across the world, 2021 was a special year for many reasons -- a period of great uncertainty due to the